Group 1 - Fulin Precision's subsidiary Jiangxi Shenghua invested 270 million yuan to establish a joint venture for a 500,000-ton ferrous oxalate project, with a total investment of 1.5 billion yuan expected to be completed by September 30, 2026 [1] - Xuguang Electronics plans to raise up to 1 billion yuan through a private placement to fund high-voltage vacuum arc extinguishing chamber expansion and other projects [2] - Minexplosion Optoelectronics intends to acquire 100% equity of Xiazhi Precision, with the transaction subject to shareholder and regulatory approvals [3] Group 2 - Shangluo Electronics' controlling shareholder plans to reduce his stake by up to 3% due to personal financial needs [4] - Babi Food reported a 1.3% decline in net profit for 2025, despite an 11.22% increase in revenue [5] - Pengding Holdings' subsidiary acquired industrial land in Huai'an for 66.14 million yuan [6] Group 3 - Zhuoyue New Energy's net profit for 2025 increased by 14.16%, despite a 17.43% decline in revenue [7] - Zhongyuan Media's net profit grew by 30.99% in 2025, with revenue decreasing by 5.13% [8] - Huangshan Tourism plans to invest approximately 530 million yuan in a hotel project with a 24-month construction period [9] Group 4 - *ST Jinling's restructuring plan was approved by the court, which may improve the company's financial situation [11] - Jichuan Pharmaceutical's subsidiary paid 80 million yuan for exclusive commercialization rights of a drug [12] - Pilin Bio's subsidiary received a notice for the acceptance of a drug supplement application [13] Group 5 - Nepe Mining terminated its investment in Swiss Veritas Resources AG due to changes in conditions [14] - Jinhui Wine announced a cash dividend of 0.20 yuan per share for the first three quarters of 2025 [15] - Hualan Biological's clinical trial for a new drug received approval for an additional indication [16] Group 6 - Industrial Fulian reported a total of 247 million yuan spent on share buybacks as of January 31, 2026 [17] - Yitong Century was pre-selected for a 107 million yuan project with China Tower [18] - Wanfeng Co. noted uncertainty in future price changes for disperse dyes [19] Group 7 - Bibet's clinical trial application for a new drug was approved by the National Medical Products Administration [21] - Chengbang Co. signed new project contracts worth 40.03 million yuan in Q4 2025 [22] - *ST Hengji received a court ruling for a performance compensation of 175 million yuan [23] Group 8 - Jihua Group is planning a change in control, leading to continued stock suspension [24] - Ningbo Port expects a container throughput of 5.03 million TEUs in January 2026, a 9.5% increase [25] - Hengli Petrochemical's actual controller increased his stake by 3.3 million shares [26] Group 9 - Hongfuhan signed a sales contract worth 480 million yuan with Guangdong Quanxiang [27] - All New Good's shareholder lifted a judicial freeze on 4.36% of the company's shares [28] - Changchun High-tech's subsidiary's clinical trial application for a new drug was accepted [29] Group 10 - Xingqi Eye Medicine's clinical trial for a new drug entered the first/second phase [31] - Hanma Technology reported a 140.04% increase in new energy heavy truck production in January 2026 [32] - Hengfeng Paper plans to invest 349 million yuan in a new green printing project [33] Group 11 - Zhifei Biological's mRNA vaccine for shingles received clinical trial approval [34] - Yutong Bus reported a 15.35% decrease in production in January 2026 [35] - StarNet Ruijie plans to sign a lease contract with an affiliate for a total rent of up to 110 million yuan [36] Group 12 - Hacheng Bonda's director completed a 0.97% share reduction [37] - Hendi Pharmaceutical's application for a new drug was approved [38] - Xinhua Medical's subsidiary received a medical device registration certificate [40] Group 13 - Yaokang Bio reported a 31.49% increase in net profit for 2025 [41] - Gaotie Electric reported a 14.02% increase in net profit for 2025 [42]

黄山旅游发展股份有限公司 对外投资管理办法 （四）对子公司增资扩股或对其他公司增资入股； （五）设立并购基金或产业基金等战略型或财务型投资业务。 本办法所述对外投资不包括固定资产投资、股票投资、债券投资、期货投资、 期权投资、委托理财及投资其他金融衍生品种等金融投资活动。 （2026 年 2 月修订） 第一章 总则 第一条 为建立规范、有效、科学的投资决策体系和机制，进一步加强黄山 旅游发展股份有限公司（以下简称"公司"）的对外投资管理，规范投资行为，防 范投资风险，提高投资效益，根据《中华人民共和国民法典》、《中华人民共和国 公司法》、《企业国有资产交易监督管理办法》、《黄山市市属企业重大事项监督管 理办法》及有关国资监管规定等法律、法规和《公司章程》，制定本办法。 第二条 本办法所称对外投资，是指以货币资金、实物资产、无形资产以及 法律法规允许的其他方式，进行的各种形式的对外投资活动，包括但不限于： （一）全资或与他人合资新设公司； （二）部分或全部收购其他公司资产或股权； （三）公司内部母子公司及子公司间的股权转让； 第三条 对外投资管理是指对外投资项目的投前论证、投中实施和投后管理 的全流程管理。投前 ...

证券代码：600054(Ａ股) 股票简称：黄山旅游(Ａ股) 编号：2026-005 900942(Ｂ股) 黄山Ｂ股(Ｂ股) 黄山旅游发展股份有限公司 关于投资建设黄山滨江东路 12 号酒店项目的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 风险提示：项目建设期间可能受材料、劳动力成本等要素价格波动、施工 管理、部分未预见费用增加等诸多因素影响，从而影响项目的建设成效。受经济 环境、宏观政策、市场情况以及经营管理等多方面因素的影响，项目在经营过程 中可能存在不达预期收益的风险。 一、项目投资概述 1、根据 2024 年 12 月 13 日公司第九届董事会第五次会议决议，同意公司参 与安徽省黄山市屯溪区滨江东路 12 号利港尚公馆 1 幢 29 套在建工程（含配套对 应的地下室）司法拍卖竞买资产（详见公司 2024-042 号公告）。根据淘宝网司 法拍卖网络平台于 2024 年 12 月 17 日公示的《网络竞价成功确认书》，公司以 16,530.63 万元竞拍取得上述资产（详见公司 2024-043 ...

证券代码：600054(Ａ股) 股票简称：黄山旅游(Ａ股) 编号：2026-004 900942(Ｂ股) 黄山Ｂ股(Ｂ股) 黄山旅游发展股份有限公司 第九届董事会第十九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 黄山旅游发展股份有限公司（以下简称"公司"）第九届董事会第十九次会 议通知于 2026 年 1 月 31 日以书面送达、传真或者电子邮件等方式发出，会议于 2026 年 2 月 3 日以通讯表决方式召开。本次会议应出席董事 11 名，实际出席董 事 11 名。本次会议由公司董事长章德辉先生召集并主持。本次会议的召开符合 《公司法》和《公司章程》的有关规定。本次会议审议情况如下： 一、审议通过了《关于投资建设黄山滨江东路 12 号酒店项目的议案》； 表决结果：同意 11 票，反对 0 票，弃权 0 票。 会议同意公司投资建设黄山滨江东路 12 号酒店项目，预计投资金额约为 5.3 亿元（具体以实际投资金额为准）。 二、审议通过了《关于修订<对外投资管理办法>的议案》。 表决结果：同意 11 票，反对 ...

格隆汇2月3日丨黄山旅游(600054.SH)公布，随着黄山市大交通格局的不断完善，为顺应黄山市旅游发 展趋势，丰富目的地旅游产品供给，公司于2026年2月3日召开第九届董事会第十九次会议，审议通过了 《关于投资建设黄山滨江东路12号酒店项目的议案》，同意公司投资建设黄山滨江东路12号酒店项目， 预计投资金额约为5.3亿元（具体以实际投资金额为准），资金来源为公司自筹资金。 ...

每经AI快讯，2月3日，黄山旅游(600054.SH)公告称，公司计划投资约5.3亿元建设黄山滨江东路12号酒 店项目，资金来源为自筹资金。该项目位于黄山市中心政务区及商务区范围核心，属于中心城区稀缺地 块，区位优势明显。项目主要内容包括对原建筑进行结构加固与空间优化，重构公共区域动线，客房配 置约490间，并按照国际品牌标准对各功能区域实施精装。项目建设周期预计为24个月。 ...

智通财经APP讯，黄山旅游(600054.SH)发布公告，公司投资建设黄山滨江东路12号酒店项目，预计投 资金额约为5.3亿元(具体以实际投资金额为准)，资金来源为公司自筹资金。项目建设周期预计为24个月 (不含前期工作)(具体以实际建设周期为准)。 本次投资建设黄山滨江东路12号酒店项目，是公司顺应黄山市大交通格局完善及旅游发展趋势所作出的 举措，有利于进一步优化公司高端酒店会议、客房、餐饮等设施配比，丰富酒店产品供给及产品结构。 ...

本次投资建设黄山滨江东路12号酒店项目，是公司顺应黄山市大交通格局完善及旅游发展趋势所作出的 举措，有利于进一步优化公司高端酒店会议、客房、餐饮等设施配比，丰富酒店产品供给及产品结构。 黄山旅游（600054）(600054.SH)发布公告，公司投资建设黄山滨江东路12号酒店项目，预计投资金额 约为5.3亿元(具体以实际投资金额为准)，资金来源为公司自筹资金。项目建设周期预计为24个月(不含 前期工作)(具体以实际建设周期为准)。 ...

黄山旅游公告，公司于2026年2月3日召开第九届董事会第十九次会议，审议通过了《关于投资建设黄山 滨江东路12号酒店项目的议案》，同意公司投资建设黄山滨江东路12号酒店项目，预计投资金额约为 5.3亿元，资金来源为公司自筹资金。该项目位于黄山市中心政务区及商务区核心，总建筑面积79178.15 平方米，目前建筑主体已完成。公司将对既有建筑实施全面改造与品质升级，打造高端酒店。项目建设 周期预计为24个月，静态投资回收期为16.14年。 ...

Summary of Key Points from Conference Call Records Industry Overview - **Consumer Sector**: Increased policy emphasis on consumption, with the "14th Five-Year Plan" and Central Economic Work Conference highlighting its importance. The later Lunar New Year in 2026 is expected to benefit consumer goods sales, particularly in travel-related and spiritual consumption sectors. Companies like Wei Long, Dongpeng, and Baiya are noted for their growth potential [1][3][4]. - **Agriculture Sector**: Expected to perform well in 2026, with most agricultural products in a bottoming phase. Key areas to watch include cattle breeding, pig farming, and edible mushrooms post-Lunar New Year [2][15][16]. Key Companies and Sub-sectors - **Consumer Goods**: - **Wei Long and Dongpeng**: Anticipated growth rates over 20%, currently priced relatively low [4]. - **Baiya**: Strong offline performance, with profits expected to reach 420 million yuan, entering a value phase [6]. - **Traditional Home Furnishing**: - Companies like Gujia Home are recommended as the sector has reached a cyclical bottom, with low valuations and strong recovery potential [7][9]. - **Raw Materials**: - Companies like Xinghao and Bailong Oriental are performing well due to rising raw material prices, with significant growth in order and delivery data [10]. - **Domestic Demand**: - Leading companies such as Bosideng, Luolai Life, and Jiangnan Buyi are expected to outperform the industry average growth in 2026, presenting good investment value [12]. Emerging Markets and New Products - **AI Glasses Market**: Expected growth in 2026-2027, with Ray-Ban Meta glasses projected to exceed 10 million units in shipments by 2026. Companies like Kanglaite Optical and Yutong Technology are recommended for tracking [5]. Investment Opportunities - **Consumer Sector**: - Current best time to invest in the consumer sector as many companies are still in a bear market. The emphasis on consumption by the government is expected to enhance the sector's value [3]. - **Traditional Home Furnishing**: - The sector is at a low valuation and is expected to recover, making it a good opportunity for investment [7][9]. - **Agriculture**: - Post-Lunar New Year, the agriculture sector is expected to enter a recovery phase, with specific focus on cattle, pig farming, and edible mushrooms [16][17]. - **Food and Beverage**: - Companies like Guizhou Moutai and Luzhou Laojiao are highlighted for their potential growth, with the overall sector expected to see a 20-30% increase due to low valuations and potential catalysts [27][28]. Additional Insights - **Consumer Behavior**: The later Lunar New Year is expected to extend the sales season, benefiting various consumer goods [3]. - **Market Dynamics**: The agriculture sector is expected to show a recovery after a period of weakness, with potential for significant returns in the coming quarters [15][16]. - **Investment Strategy**: Focus on companies with strong fundamentals and growth potential, particularly in sectors that are currently undervalued or have strong recovery prospects [12][27].